InsidersTradesSigma
Carasent AB (publ) Stock: price and management transactions · Finland · FIN-FSA
Follow the Carasent AB (publ) stock price and the full insider trade history of the company, a listed equity based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Healthcare & Pharma sector, Carasent AB (publ) has logged 5 reports. Market capitalisation: €1.5bn. The latest transaction was filed on 13 May 2026 (Purchase). Among the most active insiders: Daniel Öhman. The full history is openly available.
5
Insider Decl.
0
Thresholds
€29,683
4 ops.
Buy Volume
€124,120
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Carasent AB (publ) Strong Buy (bullish), based on 2 analysts. Average price target: SEK 36.25.
32Σ signal
Fundamental score
Ranked 11,109 of 26,092 companies
55.7
score / 100
Value39
Quality72
FCF yld-0.0%
Earn yld2.3%
EV/EBITDA16.1x
ROE4.9%
Gross mgn84%
Net mgn10%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 13 May 2026
Declarations5 total
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
9,000 shares@ SEK 3.680.0002% mcap50.0% of flowTeckningsoptionFI:csv-125af0e4256a4f306bbc
Ideal exit: 6 Feb 2027 (T+270)
35,000 shares@ SEK 3.680.0008% mcap8.0% of flowTeckningsoptionFI:csv-f71770e4cc22e06052a7
Ideal exit: 6 Feb 2027 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
9,000 shares@ SEK 3.68580.0002% mcap100.0% of flowTeckningsoptionFI:A003Y573-1
Ideal exit: 6 Feb 2027 (T+270)
35,000 shares@ €0.33730.0006% mcap8.7% of flowTeckningsoptionFI:A003Y522-1
Ideal exit: 6 Feb 2027 (T+270)
51,000 shares@ €2.43370.0066% mcap91.3% of flowAktieFI:A003S984-1
5 of 5 declarations
About Carasent AB (publ)
Carasent AB (publ) is a publicly traded company on the Stockholm Stock Exchange, specializing in the health and pharmaceutical sector. It focuses on developing digital solutions to enhance patient care.
